Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ads Free, Unlimited access)​
NO CREDIT CARD REQUIRED
HIMS
Upturn stock ratingUpturn stock rating

Hims Hers Health Inc (HIMS)

Upturn stock ratingUpturn stock rating
$25.41
Delayed price
Today's Top Performer Top performer
upturn advisory
PASS
  • BUY Advisory
  • Profitable SELL
  • Loss-Inducing SELL
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock infoUpturn Stock info Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK

Upturn Advisory Summary

01/10/2025: HIMS (5-star) is currently NOT-A-BUY. Pass it for now.

Upturn Star Rating

ratingratingratingratingrating

Outstanding Performance

These Stocks/ETFs, based on Upturn Advisory, have historically outperformed the market, making them a top-tier choice for investors.

AI Based Fundamental Rating

ratingratingratingratingrating

Outstanding Performance

These Stocks/ETFs, based on Upturn Advisory, have historically outperformed the market, making them a top-tier choice for investors.

Analysis of Past Performance

Type Stock
Historic Profit 331.94%
Avg. Invested days 37
Today’s Advisory PASS
Upturn Star Rating Upturn stock ratingUpturn stock rating
Upturn Advisory Performance Upturn Advisory Performance 5.0
Stock Returns Performance Upturn Returns Performance 5.0
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 01/10/2025

Key Highlights

Company Size Mid-Cap Stock
Market Capitalization 5.66B USD
Price to earnings Ratio 58.86
1Y Target Price 26.2
Price to earnings Ratio 58.86
1Y Target Price 26.2
Volume (30-day avg) 12590902
Beta 1.06
52 Weeks Range 8.14 - 35.02
Updated Date 01/14/2025
52 Weeks Range 8.14 - 35.02
Updated Date 01/14/2025
Dividends yield (FY) -
Basic EPS (TTM) 0.44

Earnings Date

Report Date -
When -
Estimate -
Actual -

Profitability

Profit Margin 8.15%
Operating Margin (TTM) 5.57%

Management Effectiveness

Return on Assets (TTM) 5.66%
Return on Equity (TTM) 26.35%

Valuation

Trailing PE 58.86
Forward PE 53.48
Enterprise Value 5415896051
Price to Sales(TTM) 4.56
Enterprise Value 5415896051
Price to Sales(TTM) 4.56
Enterprise Value to Revenue 4.36
Enterprise Value to EBITDA 95.7
Shares Outstanding 210100992
Shares Floating 189041238
Shares Outstanding 210100992
Shares Floating 189041238
Percent Insiders 11.44
Percent Institutions 64.3

AI Summary

Company Profile:

Hims Hers Health Inc is a telehealth platform that offers personalized healthcare solutions for a variety of medical conditions across multiple areas including dermatology, sexual health, hair care, mental health, and primary care. The company was founded in 2017 and is headquartered in San Francisco, California. Hims Hers Health Inc aims to make healthcare more accessible and affordable for individuals by providing online consultations, personalized treatment plans, and convenient delivery of medications.

The leadership team of Hims Hers Health Inc is led by Andrew Dudum, the CEO and founder of the company. The corporate structure includes various departments such as medical, marketing, technology, and operations, all working together to deliver comprehensive healthcare services to customers.

Top Products and Market Share:

Hims Hers Health Inc's top products include prescription medications, over-the-counter treatments, supplements, and personalized health kits. The company has gained significant market share in the telehealth industry, especially in the United States, by providing convenient and discreet healthcare solutions to consumers. The products have been well-received by customers, leading to repeat purchases and positive reviews.

Total Addressable Market:

The total addressable market for Hims Hers Health Inc includes individuals seeking efficient and cost-effective healthcare solutions for common medical issues such as acne, hair loss, erectile dysfunction, and anxiety. The company targets a wide range of demographics, including millennials and Gen Z, who are more inclined towards online healthcare services.

Financial Performance:

Hims Hers Health Inc has shown strong financial performance in recent years, with consistent revenue growth, narrowing losses, and improved profit margins. The company's earnings per share (EPS) have also shown a positive trend, reflecting the overall financial health of the business. Cash flow statements and balance sheets indicate a solid financial position and liquidity for future growth opportunities.

Dividends and Shareholder Returns:

As a growth-oriented company, Hims Hers Health Inc does not currently pay dividends to shareholders. However, the stock has shown significant appreciation in value, leading to attractive shareholder returns over the years. Investors have benefited from capital appreciation as the company continues to expand its market presence and offerings.

Growth Trajectory:

Hims Hers Health Inc has demonstrated impressive growth over the past few years, expanding its product portfolio, entering new markets, and forming strategic partnerships. The company's future growth prospects look promising, driven by increasing demand for telehealth services, advancements in technology, and a growing customer base. Recent product launches and initiatives indicate a strong growth trajectory for the company.

Market Dynamics:

The telehealth industry is experiencing rapid growth, driven by changing consumer preferences, technological advancements, and the need for remote healthcare solutions. Hims Hers Health Inc is well-positioned within the industry, leveraging its online platform and personalized approach to meet the evolving needs of customers. The company's adaptability to market changes and ability to innovate further solidify its position in the industry.

Competitors:

Key competitors of Hims Hers Health Inc include Teladoc Health Inc (TDOC) and Ro Health Inc (RO). While these competitors also offer telehealth services, Hims Hers Health Inc differentiates itself through its focus on personalized care, discreet delivery of medications, and user-friendly platform. Market share percentages show Hims Hers Health Inc's competitive advantage in certain segments, but there is still intense competition in the telehealth space.

Potential Challenges and Opportunities:

Key challenges for Hims Hers Health Inc include regulatory changes, competition from other telehealth providers, and the need to maintain quality of care while scaling operations. However, there are also significant opportunities for the company, such as expanding into new markets, launching innovative products, and forming strategic partnerships with healthcare providers and insurers.

Recent Acquisitions (last 3 years):

Hims Hers Health Inc has not made any significant acquisitions in the last 3 years. However, the company may consider acquisitions in the future to enhance its product offerings, expand its market presence, or acquire new technologies that align with its overall strategy.

AI-Based Fundamental Rating:

Based on an AI-based rating system, Hims Hers Health Inc's stock fundamentals receive a rating of 8 out of 10. This rating is justified by the company's strong financial performance, market positioning, and future growth prospects. Hims Hers Health Inc's solid leadership team, innovative approach to healthcare, and ability to adapt to market dynamics contribute to its favorable rating.

Sources and Disclaimers:

Sources used for this analysis include company reports, financial statements, industry publications, and reputable financial websites. This overview is for informational purposes only and should not be used as investment advice. Investors are advised to conduct their own research and consult with financial advisors before making investment decisions.

About NVIDIA Corporation

Exchange NYSE
Headquaters San Francisco, CA, United States
IPO Launch date 2019-09-13
Co-Founder, Chairman & CEO Mr. Andrew Dudum
Sector Consumer Defensive
Industry Household & Personal Products
Full time employees 1046
Full time employees 1046

Hims & Hers Health, Inc. operates a telehealth platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, cosmetics, and supplement products primarily focusing on general wellness, sexual health and wellness, skincare, and hair care. In addition, the company's curated non-prescription products include melatonin and biotin in the wellness specialty category; moisturizers, creams, sunscreen, serum, face oil, and face wash in the skincare specialty; condoms, climax delay spray and wipes, vibrators, and lubricants in the sexual health and wellness specialty; and shampoos, conditioners, scalp scrubs, and topical treatments, such as minoxidil in the hair care specialty category. Further, it offers medical consultation and post-consultation support services, as well as health and wellness products through wholesale partners. Hims & Hers Health, Inc. is based in San Francisco, California.

Upturn is now on iOS and Android!

Experience Upturn on your mobile. Install it now!​